Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.610
-0.230 (-12.50%)
At close: Aug 1, 2025, 4:00 PM
1.680
+0.070 (4.35%)
After-hours: Aug 1, 2025, 7:58 PM EDT
Accolade Employees
Pulmonx had 291 employees as of December 31, 2024. The number of employees increased by 12 or 4.30% compared to the previous year.
Employees
291
Change (1Y)
12
Growth (1Y)
4.30%
Revenue / Employee
$311,165
Profits / Employee
-$195,670
Market Cap
64.81M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 291 | 12 | 4.30% |
Dec 31, 2023 | 279 | 10 | 3.72% |
Dec 31, 2022 | 269 | 16 | 6.32% |
Dec 31, 2021 | 253 | 33 | 15.00% |
Dec 31, 2020 | 220 | 40 | 22.22% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LUNG News
- 2 days ago - Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Pulmonx Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 16 days ago - Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 - GlobeNewsWire
- 2 months ago - Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference - GlobeNewsWire
- 3 months ago - Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Pulmonx Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - EDAP Appoints Glen French to Board of Directors - GlobeNewsWire